Immunohistochemical parameters of serous ovarian carcinomas and possible mechanism of development of resistance to platinum-based drugs

Автор: Zhukova G.V., Ulyanova E.P., Menshenina A.P., Moiseenko T.I., Zlatnik E.Yu., Nepomnyashchaya E.M., Sagakyants A.B., Verenikina T.I.

Журнал: Сибирский онкологический журнал @siboncoj

Рубрика: Лабораторные и экспериментальные исследования

Статья в выпуске: 4 т.23, 2024 года.

Бесплатный доступ

The aim of the study was to evaluate a prognostic significance of immunohistochemical parameters in serous ovarian carcinomas and their statistical relationships after neoadjuvant treatment to assess the development of tumor resistance to platinum-containing adjuvant polychemotherapy regimens. Material and Methods. An immunohistochemical study of tumor tissue was carried out in patients with high-grade serous ovarian cancer (stage IIIC-IV). The age of the patients ranged from 49-72 years. There were 59 patients who were sensitive and 22 patients who were resistant to platinum-containing adjuvant polychemotherapy. In the tissue of ovarian tumors obtained during surgery after noadjuvant polychemotherapy, we studied immunohistochemical indicators of proliferative activity (Ki67), expression of the DNA excision repair protein ERCC1 and proteins of the ABC transporter family - Pgp and BCRP, as well as statistical relationships between these indicators (Spearman’s rank correlation coefficient).

Еще

High-grade serous ovarian cancer, platinum resistance, proliferation, transport proteins, statistical relationship, biofeedback

Короткий адрес: https://sciup.org/140307088

IDR: 140307088   |   DOI: 10.21294/1814-4861-2024-23-4-45-53

Статья научная